id	sid	tid	token	lemma	pos
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	1	Sleeping	sleep	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	2	Beauty	Beauty	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	3	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	4	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	5	Story	Story	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	6	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	7	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	8	Bacille	Bacille	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	9	Calmette	Calmette	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	10	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	11	Guérin	Guérin	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	12	Vaccine	Vaccine	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	13	Sleeping	Sleeping	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	14	Beauty	Beauty	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	15	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	16	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	17	Story	Story	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	18	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	19	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	20	Bacille	Bacille	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	21	Calmette	Calmette	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	22	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	23	Guérin	Guérin	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	24	Vaccine	Vaccine	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	25	Helen	Helen	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	26	A.	A.	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	27	Fletcher	Fletcher	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	28	Department	Department	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	29	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	30	Immunology	Immunology	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	31	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	32	Infection	Infection	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	33	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	34	London	London	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	35	School	School	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	36	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	37	Hygiene	Hygiene	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	38	&	&	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	39	Tropical	Tropical	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	40	Medicine	Medicine	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	41	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	42	London	London	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	43	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	44	United	United	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	45	Kingdom	Kingdom	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	46	ABSTRACT	ABSTRACT	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	47	Mycobacterium	Mycobacterium	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	48	bovis	bovi	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	49	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	50	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	51	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	52	only	only	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	53	available	available	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	54	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	55	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	56	protection	protection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	57	against	against	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	58	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	59	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	60	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	61	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	1	62	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	1	While	while	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	2	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	3	protects	protect	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	4	children	child	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	5	from	from	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	6	severe	severe	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	7	disease	disease	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	8	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	9	it	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	10	has	have	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	11	little	little	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	12	impact	impact	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	13	on	on	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	14	pulmonary	pulmonary	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	15	disease	disease	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	16	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	17	adults	adult	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	2	18	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	1	A	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	2	recombinant	recombinant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	3	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	4	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	5	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	6	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	7	ureC::hly	urec::hly	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	8	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	9	strain	strain	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	10	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	11	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	12	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	13	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	14	advanced	advanced	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	15	clinical	clinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	16	trials	trial	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	17	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	18	shows	show	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	19	promise	promise	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	20	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	21	improved	improved	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	22	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	23	safety	safety	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	24	but	but	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	25	little	little	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	26	change	change	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	27	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	28	efficacy	efficacy	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	29	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	30	ani-	ani-	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	31	mal	mal	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	32	models	model	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	3	33	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	1	A	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	2	second	second	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	3	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	4	generation	generation	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	5	recombinant	recombinant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	6	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	7	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	8	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	9	an	an	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	10	additional	additional	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	11	deletion	deletion	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	12	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	13	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	14	nuoG	nuoG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	15	gene	gene	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	16	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	17	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	18	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	19	ureC::hly	urec::hly	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	20	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	21	nuoG	nuoG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	22	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	23	shows	show	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	24	improved	improved	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	25	efficacy	efficacy	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	26	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	27	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	28	mouse	mouse	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	29	model	model	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	30	compared	compare	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	31	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	32	that	that	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	33	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	34	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	4	35	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	1	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	2	was	be	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	3	first	first	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	4	used	use	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	5	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	6	humans	human	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	7	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	8	1921	1921	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	9	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	10	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	11	like	like	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	12	Sleeping	sleep	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	13	Beauty	Beauty	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	14	pricked	prick	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	15	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	16	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	17	spinning	spinning	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	18	wheel	wheel	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	19	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	20	we	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	21	have	have	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	22	slept	sleep	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	23	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	24	100	100	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	25	years	year	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	26	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	27	showing	show	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	28	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	29	reluctance	reluctance	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	30	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	31	invest	invest	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	32	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	33	clinical	clinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	34	devel-	devel-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	35	opment	opment	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	36	or	or	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	37	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	38	biomanufacturing	biomanufacture	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	39	capacity	capacity	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	40	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	41	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	42	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	5	43	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	1	The	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	2	advance	advance	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	3	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	4	recombinant	recombinant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	5	BCGs	bcg	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	6	should	should	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	7	awaken	awaken	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	8	us	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	9	from	from	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	10	our	-PRON-	PRP$
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	11	sleep	sleep	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	12	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	13	call	call	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	14	us	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	15	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	16	invest	invest	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	17	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	18	new	new	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	19	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	20	generation	generation	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	21	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	22	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	23	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	24	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	25	protect	protect	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	26	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	27	biomanufacture	biomanufacture	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	28	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	29	our	-PRON-	PRP$
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	30	current	current	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	31	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	32	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	6	33	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	1	BACKGROUND	BACKGROUND	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	2	Nearly	nearly	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	3	2	2	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	4	million	million	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	5	people	people	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	6	die	die	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	7	each	each	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	8	year	year	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	9	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	10	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	11	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	12	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	13	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	14	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	15	andan	andan	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	16	estimated	estimate	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	17	one	one	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	18	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	19	third	third	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	20	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	21	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	22	world	world	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	23	’s	’s	POS
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	24	population	population	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	25	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	26	in-	in-	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	27	fected	fecte	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	28	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	29	Mycobacterium	mycobacterium	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	30	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	31	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	32	1	1	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	33	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	7	34	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	1	In	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	2	2015	2015	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	4	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	5	was	be	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	6	reported	report	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	7	as	as	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	8	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	9	leading	lead	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	10	cause	cause	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	11	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	12	death	death	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	13	due	due	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	14	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	15	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	16	single	single	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	17	infectious	infectious	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	18	disease	disease	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	19	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	20	2	2	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	21	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	8	22	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	1	Improved	improved	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	2	diagnostics	diagnostic	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	3	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	4	shorter	short	JJR
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	5	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	6	less	less	RBR
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	7	toxic	toxic	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	8	drug	drug	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	9	treatments	treatment	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	10	would	would	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	11	help	help	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	12	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	13	reduce	reduce	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	14	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	15	global	global	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	16	burden	burden	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	17	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	18	disease	disease	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	19	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	20	but	but	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	21	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	22	significant	significant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	23	impact	impact	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	24	on	on	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	25	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	26	rate	rate	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	27	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	28	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	29	disease	disease	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	30	can	can	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	31	only	only	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	32	be	be	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	33	made	make	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	34	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	35	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	36	more	more	RBR
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	37	effective	effective	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	38	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	39	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	40	http://www.who.int/tb/	http://www.who.int/tb/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	41	post2015_strategy	post2015_strategy	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	42	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	43	en/	en/	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	44	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	45	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	46	3	3	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	47	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	9	48	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	1	Bacille	Bacille	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	2	Calmette	Calmette	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	3	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	4	Guérin	Guérin	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	5	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	6	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	7	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	8	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	9	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	10	only	only	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	11	currently	currently	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	12	licensed	license	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	13	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	14	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	15	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	16	prevention	prevention	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	17	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	18	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	10	19	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	1	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	2	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	3	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	4	live	live	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	5	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	6	attenuated	attenuate	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	7	strain	strain	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	8	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	9	Mycobacterium	Mycobacterium	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	10	bovis	bovis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	11	that	that	WDT
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	12	was	be	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	13	attenuated	attenuate	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	14	through	through	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	15	passage	passage	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	16	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	17	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	18	organism	organism	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	19	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	20	culture	culture	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	21	more	more	JJR
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	22	than	than	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	23	230	230	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	24	times	time	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	11	25	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	1	Seed	seed	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	2	stock	stock	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	3	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	4	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	5	was	be	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	6	distributed	distribute	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	7	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	8	other	other	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	9	manufacturers	manufacturer	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	10	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	11	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	12	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	13	process	process	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	14	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	15	attenuation	attenuation	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	16	continued	continue	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	17	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	18	resulting	result	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	19	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	20	more	more	JJR
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	21	than	than	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	22	16	16	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	23	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	24	4	4	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	25	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	26	distinct	distinct	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	27	strains	strain	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	28	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	29	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	30	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	31	worldwide	worldwide	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	12	32	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	1	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	2	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	3	one	one	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	4	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	5	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	6	most	most	RBS
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	7	widely	widely	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	8	used	use	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	9	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	10	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	11	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	12	world	world	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	13	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	14	but	but	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	15	its	-PRON-	PRP$
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	16	efficacy	efficacy	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	17	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	18	highly	highly	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	19	variable	variable	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	13	20	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	1	In	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	2	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	3	recent	recent	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	4	meta-	meta-	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	5	analysis	analysis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	6	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	7	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	8	literature	literature	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	10	it	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	11	was	be	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	12	shown	show	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	13	that	that	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	14	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	15	efficacy	efficacy	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	16	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	17	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	18	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	19	lower	low	JJR
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	20	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	21	those	those	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	22	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	23	previous	previous	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	24	exposure	exposure	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	25	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	26	environmental	environmental	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	27	myco-	myco-	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	28	bacteria	bacteria	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	29	or	or	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	30	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	31	M.	M.	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	32	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	33	itself	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	34	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	35	as	as	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	36	assessed	assess	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	37	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	38	reactivity	reactivity	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	39	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	40	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	41	tuberculin	tuberculin	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	42	skin	skin	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	43	test	test	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	44	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	45	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	46	5	5	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	47	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	14	48	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	1	The	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	2	efficacy	efficacy	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	3	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	4	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	5	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	6	countries	country	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	7	where	where	WRB
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	8	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	9	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	10	endemic	endemic	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	11	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	12	therefore	therefore	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	13	highest	high	JJS
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	14	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	15	unexposed	unexposed	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	16	infants	infant	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	17	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	18	lowest	low	JJS
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	19	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	20	adults	adult	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	21	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	22	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	23	an	an	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	24	average	average	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	25	efficacy	efficacy	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	26	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	27	50	50	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	28	%	%	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	29	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	30	children	child	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	31	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	32	typically	typically	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	33	no	no	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	34	efficacy	efficacy	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	35	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	36	adults	adult	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	15	37	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	1	The	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	2	importance	importance	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	3	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	4	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	5	Th1	th1	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	6	pathway	pathway	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	7	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	8	protective	protective	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	9	immunity	immunity	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	10	has	have	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	11	been	be	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	12	confirmed	confirm	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	13	through	through	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	14	multiple	multiple	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	15	observations	observation	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	16	from	from	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	17	human	human	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	18	genetic	genetic	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	19	studies	study	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	20	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	21	murine	murine	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	22	M.	M.	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	23	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	24	challenge	challenge	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	25	experiments	experiment	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	16	26	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	1	In	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	2	South	south	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	3	African	african	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	4	infants	infant	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	5	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	6	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	7	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	8	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	9	specific	specific	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	10	gamma	gamma	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	11	interferon	interferon	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	12	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	13	IFN-	IFN-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	14	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	15	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	16	enzyme	enzyme	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	17	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	18	linked	link	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	19	immunosorbent	immunosorbent	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	20	spot	spot	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	21	assay	assay	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	22	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	23	ELISPOT	ELISPOT	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	24	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	25	response	response	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	26	was	be	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	27	associated	associate	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	28	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	29	reduced	reduce	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	30	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	31	disease	disease	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	32	risk	risk	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	33	over	over	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	34	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	35	following	follow	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	36	1	1	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	37	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	38	3	3	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	39	years	year	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	40	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	41	life	life	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	42	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	43	6	6	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	44	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	17	45	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	1	This	this	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	2	immune	immune	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	3	response	response	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	4	was	be	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	5	pre-	pre-	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	6	dominantly	dominantly	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	7	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	8	CD4	CD4	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	9	�	�	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	10	polyfunctional	polyfunctional	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	11	response	response	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	13	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	14	little	little	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	15	detection	detection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	16	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	17	antigen	antigen	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	18	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	19	specific	specific	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	20	CD8	CD8	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	21	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	22	T	t	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	23	cells	cell	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	24	at	at	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	25	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	26	time	time	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	27	point	point	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	28	tested	test	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	29	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	30	4	4	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	31	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	32	6	6	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	33	months	month	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	34	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	35	age	age	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	36	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	37	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	38	6	6	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	39	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	18	40	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	1	New	new	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	2	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	3	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	4	seek	seek	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	5	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	6	improve	improve	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	7	protection	protection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	8	against	against	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	9	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	10	either	either	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	11	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	12	increasing	increase	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	13	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	14	magnitude	magnitude	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	15	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	16	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	17	CD4	CD4	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	18	T	T	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	19	cell	cell	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	20	response	response	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	21	induced	induce	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	22	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	23	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	24	or	or	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	25	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	26	broadening	broaden	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	27	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	28	immune	immune	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	29	response	response	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	30	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	31	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	32	example	example	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	33	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	34	through	through	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	35	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	36	induction	induction	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	37	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	38	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	39	CD8	CD8	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	40	T	T	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	41	cell	cell	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	42	response	response	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	19	43	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	1	Strategies	strategy	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	2	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	3	improved	improved	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	4	protection	protection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	5	include	include	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	6	whole	whole	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	7	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	8	mycobacterial	mycobacterial	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	9	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	10	cell	cell	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	11	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	12	derived	derive	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	13	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	14	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	15	virus	virus	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	16	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	17	vectored	vectore	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	18	subunit	subunit	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	19	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	20	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	21	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	22	adjuvanted	adjuvante	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	23	protein	protein	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	24	subunit	subunit	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	25	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	26	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	27	7	7	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	28	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	20	29	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	1	The	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	2	subunit	subunit	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	3	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	4	are	be	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	5	typically	typically	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	6	given	give	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	7	after	after	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	8	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	9	immunization	immunization	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	10	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	11	boost	boost	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	12	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	13	immune	immune	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	14	response	response	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	15	primed	prime	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	16	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	17	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	18	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	19	whereas	whereas	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	20	whole	whole	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	21	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	22	mycobacterial	mycobacterial	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	23	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	24	can	can	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	25	either	either	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	26	be	be	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	27	used	use	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	28	as	as	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	29	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	30	booster	booster	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	31	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	32	or	or	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	33	as	as	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	34	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	35	replacement	replacement	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	36	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	37	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	21	38	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	1	The	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	2	current	current	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	3	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	4	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	5	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	6	thus	thus	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	7	able	able	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	8	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	9	confer	confer	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	10	protection	protection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	11	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	12	but	but	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	13	room	room	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	14	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	15	im-	im-	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	16	proved	prove	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	17	protection	protection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	18	through	through	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	19	boosting	boost	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	20	or	or	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	21	broadening	broadening	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	22	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	23	immunity	immunity	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	24	exists	exist	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	22	25	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	1	RECOMBINANT	recombinant	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	2	BCG	bcg	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	3	VACCINES	VACCINES	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	4	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	5	�	�	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	6	ureC::hly	urec::hly	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	7	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	8	strain	strain	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	9	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	10	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	11	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	12	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	13	recombinant	recombinant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	14	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	15	strain	strain	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	16	that	that	WDT
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	17	has	have	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	18	been	be	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	19	modified	modify	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	20	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	21	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	22	insertion	insertion	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	23	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	24	listeriolysin	listeriolysin	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	25	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	26	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	27	deletion	deletion	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	28	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	29	urease	urease	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	30	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	31	8)	8)	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	23	32	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	1	These	these	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	2	modifications	modification	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	3	aim	aim	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	4	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	5	enhance	enhance	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	6	both	both	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	7	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	8	immunogenicity	immunogenicity	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	9	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	10	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	11	safety	safety	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	12	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	13	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	14	parental	parental	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	15	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	16	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	17	strain	strain	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	24	18	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	1	Listeriolysin	Listeriolysin	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	2	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	3	thought	think	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	4	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	5	perforate	perforate	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	6	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	7	phagolysosome	phagolysosome	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	8	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	9	enabling	enable	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	10	leakage	leakage	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	11	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	12	mycobacterial	mycobacterial	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	13	antigen	antigen	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	14	from	from	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	15	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	16	into	into	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	17	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	18	cytosol	cytosol	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	19	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	20	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	21	thus	thus	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	22	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	23	facilitating	facilitate	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	24	cross	cross	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	25	-	-	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	26	presentation	presentation	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	27	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	28	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	29	en-	en-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	30	hancement	hancement	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	31	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	32	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	33	CD8	CD8	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	34	T	T	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	35	cell	cell	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	36	response	response	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	37	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	38	8)	8)	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	25	39	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	1	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	2	enhances	enhance	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	3	in-	in-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	4	flammasome	flammasome	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	5	activation	activation	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	6	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	7	autophagy	autophagy	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	8	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	9	C57BL/6	C57BL/6	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	10	mice	mouse	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	11	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	12	9	9	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	13	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	14	;	;	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	15	mouse	mouse	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	16	studies	study	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	17	also	also	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	18	showed	show	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	19	an	an	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	20	association	association	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	21	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	22	central	central	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	23	memory	memory	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	24	CD4	CD4	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	25	T	T	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	26	cells	cell	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	27	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	28	T	T	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	29	follicular	follicular	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	30	helper	helper	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	31	cells	cell	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	32	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	33	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	34	increased	increase	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	35	protection	protection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	36	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	37	10	10	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	38	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	26	39	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	1	These	these	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	2	immune	immune	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	3	responses	response	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	4	are	be	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	5	broader	broad	JJR
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	6	than	than	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	7	those	those	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	8	induced	induce	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	9	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	10	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	11	parental	parental	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	12	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	13	strain	strain	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	14	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	15	where	where	WRB
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	16	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	17	CD4	CD4	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	18	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	19	Th1	th1	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	20	response	response	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	21	dominates	dominate	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	27	22	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	1	In	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	2	early	early	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	3	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	4	phase	phase	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	5	clinical	clinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	6	trials	trial	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	7	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	8	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	9	CD4	CD4	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	10	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	11	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	12	CD8	CD8	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	13	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	14	antigen	antigen	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	15	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	16	specific	specific	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	17	responses	response	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	18	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	19	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	20	did	do	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	21	not	not	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	22	differ	differ	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	23	from	from	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	24	those	those	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	25	induced	induce	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	26	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	27	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	28	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	29	although	although	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	30	there	there	EX
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	31	was	be	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	32	early	early	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	33	enhancement	enhancement	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	34	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	35	purified	purified	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	36	protein	protein	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	37	deriva-	deriva-	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	38	tive	tive	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	39	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	40	PPD)-specific	ppd)-specific	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	41	antibodies	antibody	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	42	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	43	11	11	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	44	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	28	45	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	1	Due	due	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	2	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	3	an	an	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	4	enhanced	enhanced	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	5	safety	safety	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	6	profile	profile	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	7	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	8	preclinical	preclinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	9	models	model	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	10	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	11	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	12	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	13	being	be	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	14	assessed	assess	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	15	as	as	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	16	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	17	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	18	replacement	replacement	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	19	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	20	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	21	HIV	HIV	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	22	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	23	exposed	expose	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	24	infants	infant	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	29	25	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	1	The	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	2	risk	risk	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	3	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	4	disseminated	disseminate	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	5	disease	disease	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	6	due	due	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	7	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	8	uncontrolled	uncontrolled	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	9	replication	replication	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	10	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	11	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	12	current	current	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	13	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	14	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	15	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	16	higher	high	JJR
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	17	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	18	HIV	HIV	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	19	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	20	exposed	expose	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	21	infants	infant	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	22	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	23	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	24	therefore	therefore	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	25	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	26	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	27	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	28	not	not	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	29	recom-	recom-	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	30	mended	mend	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	31	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	32	this	this	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	33	population	population	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	30	34	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	1	Phase	phase	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	2	II	ii	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	3	trials	trial	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	4	are	be	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	5	ongoing	ongoing	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	6	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	7	South	South	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	8	Africa	Africa	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	9	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	10	are	be	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	11	due	due	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	12	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	13	start	start	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	14	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	15	India	India	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	16	soon	soon	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	17	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	18	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	19	market	market	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	20	entry	entry	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	21	expected	expect	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	22	within	within	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	23	5	5	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	24	years	year	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	25	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	26	http://www.tbvi.eu/wp-content	http://www.tbvi.eu/wp-content	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	27	/uploads/2016/02	/uploads/2016/02	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	28	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	29	Grode_SII	Grode_SII	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	30	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	31	VPM	VPM	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	32	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	33	Status	status	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	34	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	35	on	on	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	36	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	37	TB	tb	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	38	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	39	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	40	-150318.pdf	-150318.pdf	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	41	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	31	42	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	1	Phase	phase	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	2	III	iii	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	3	trials	trial	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	4	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	5	prevention	prevention	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	6	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	7	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	8	recurrence	recurrence	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	9	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	10	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	11	disease	disease	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	12	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	13	those	those	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	14	previously	previously	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	15	treated	treat	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	16	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	17	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	18	are	be	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	19	also	also	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	20	expected	expect	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	21	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	22	Published	publish	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	23	30	30	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	24	August	August	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	25	2016	2016	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	26	Citation	Citation	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	27	Fletcher	Fletcher	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	28	HA	HA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	32	29	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	33	1	2016	2016	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	33	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	1	Sleeping	sleep	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	2	beauty	beauty	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	3	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	4	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	5	story	story	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	6	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	7	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	8	Bacille	Bacille	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	9	Calmette	Calmette	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	10	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	11	Guérin	Guérin	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	12	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	34	13	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	35	1	mBio	mBio	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	35	2	7(4):e01370	7(4):e01370	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	35	3	-	-	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	35	4	16	16	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	35	5	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	36	1	doi:10.1128	doi:10.1128	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	36	2	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	36	3	mBio.01370	mBio.01370	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	36	4	-	-	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	36	5	16	16	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	36	6	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	37	1	Copyright	copyright	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	37	2	©	©	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	37	3	2016	2016	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	37	4	Fletcher	Fletcher	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	37	5	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	1	This	this	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	2	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	3	an	an	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	4	open	open	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	5	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	6	access	access	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	7	article	article	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	8	distributed	distribute	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	9	under	under	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	10	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	11	terms	term	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	12	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	13	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	14	Creative	Creative	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	15	Commons	Commons	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	16	Attribution	Attribution	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	17	4.0	4.0	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	18	International	international	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	19	license	license	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	38	20	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	39	1	Address	address	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	39	2	correspondence	correspondence	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	39	3	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	39	4	Helen.Fletcher@lshtm.ac.uk	Helen.Fletcher@lshtm.ac.uk	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	39	5	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	1	COMMENTARY	COMMENTARY	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	2	crossmark	crossmark	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	3	July	July	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	4	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	5	August	August	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	6	2016	2016	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	7	Volume	volume	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	8	7	7	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	9	Issue	issue	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	10	4	4	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	11	e01370	e01370	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	12	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	13	16	16	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	14	®	®	NNPS
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	15	mbio.asm.org	mbio.asm.org	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	16	1	1	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	17	o	o	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	18	n	n	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	19	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	20	p	p	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	21	ril	ril	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	22	5	5	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	23	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	24	2	2	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	25	0	0	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	26	2	2	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	27	1	1	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	28	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	29	t	t	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	30	C	c	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	31	A	a	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	32	R	r	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	33	N	n	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	34	E	e	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	35	G	g	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	36	IE	ie	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	37	M	m	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	38	E	e	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	39	L	l	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	40	L	l	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	41	O	o	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	42	N	N	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	43	U	U	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	44	N	N	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	45	IV	IV	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	46	L	L	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	47	IB	IB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	48	R	r	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	49	h	h	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	50	ttp	ttp	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	51	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	52	//m	//m	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	53	b	b	UH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	54	io	io	UH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	55	.a	.a	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	56	sm	sm	FW
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	57	.o	.o	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	58	rg	rg	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	59	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	60	D	D	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	61	o	o	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	62	w	w	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	63	n	n	XX
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	64	lo	lo	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	65	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	66	d	d	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	67	e	e	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	68	d	d	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	69	fro	fro	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	70	m	m	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	71	http://orcid.org/0000-0002-0435-1006	http://orcid.org/0000-0002-0435-1006	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	72	http://www.who.int/tb/post2015_strategy/en/	http://www.who.int/tb/post2015_strategy/en/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	73	http://www.who.int/tb/post2015_strategy/en/	http://www.who.int/tb/post2015_strategy/en/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	74	http://www.tbvi.eu/wp-content/uploads/2016/02/Grode_SII-VPM-Status-on-TB-vaccine-150318.pdf	http://www.tbvi.eu/wp-content/uploads/2016/02/Grode_SII-VPM-Status-on-TB-vaccine-150318.pdf	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	75	http://www.tbvi.eu/wp-content/uploads/2016/02/Grode_SII-VPM-Status-on-TB-vaccine-150318.pdf	http://www.tbvi.eu/wp-content/uploads/2016/02/Grode_SII-VPM-Status-on-TB-vaccine-150318.pdf	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	76	http://www.tbvi.eu/wp-content/uploads/2016/02/Grode_SII-VPM-Status-on-TB-vaccine-150318.pdf	http://www.tbvi.eu/wp-content/uploads/2016/02/Grode_SII-VPM-Status-on-TB-vaccine-150318.pdf	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	77	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	78	http://crossmark.crossref.org/dialog/?doi=10.1128/mBio.01370-16&domain=pdf&date_stamp=2016-8-30	http://crossmark.crossref.org/dialog/?doi=10.1128/mBio.01370-16&domain=pdf&date_stamp=2016-8-30	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	79	mbio.asm.org	mbio.asm.org	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	80	http://mbio.asm.org/	http://mbio.asm.org/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	81	c	c	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	82	o	o	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	83	m	m	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	84	m	m	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	85	e	e	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	86	n	n	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	87	c	c	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	88	e	e	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	89	i	i	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	90	n	n	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	91	I	I	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	92	n	n	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	93	d	d	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	94	i	i	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	95	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	96	w	w	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	97	i	i	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	98	t	t	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	99	h	h	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	100	i	i	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	101	n	n	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	102	t	t	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	103	h	h	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	104	e	e	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	105	n	n	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	106	e	e	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	107	x	x	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	108	t	t	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	109	f	f	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	110	e	e	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	111	w	w	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	112	y	y	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	113	e	e	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	114	a	a	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	115	r	r	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	116	s	s	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	117	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	118	h	h	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	119	t	t	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	120	t	t	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	121	p	p	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	122	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	123	//indianexpress.com	//indianexpress.com	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	124	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	125	article	article	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	126	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	127	explained	explain	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	128	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	129	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	130	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	131	new	new	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	132	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	133	tb	tb	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	134	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	135	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	136	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	137	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	138	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	139	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	140	-the	-the	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	141	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	142	works	work	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	143	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	144	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	145	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	146	heres	here	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	147	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	148	why	why	WRB
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	149	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	150	india	india	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	151	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	152	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	153	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	154	excited/	excited/	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	155	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	40	156	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	1	If	if	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	2	these	these	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	3	clinical	clinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	4	trials	trial	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	5	prove	prove	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	6	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	7	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	8	be	be	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	9	safe	safe	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	10	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	11	even	even	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	12	if	if	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	13	not	not	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	14	more	more	RBR
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	15	effective	effective	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	16	against	against	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	17	clinical	clinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	18	disease	disease	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	19	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	20	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	21	will	will	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	22	be	be	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	23	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	24	first	first	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	25	new	new	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	26	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	27	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	28	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	29	enter	enter	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	30	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	31	market	market	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	32	since	since	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	33	1921	1921	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	34	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	35	when	when	WRB
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	36	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	37	was	be	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	38	first	first	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	39	used	use	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	40	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	41	humans	human	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	41	42	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	1	Research	research	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	2	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	3	recombinant	recombinant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	4	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	5	strains	strains	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	6	continues	continue	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	7	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	8	reviewed	review	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	9	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	10	reference	reference	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	11	12	12	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	12	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	42	13	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	43	1	Gengenbacher	gengenbacher	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	43	2	et	et	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	43	3	al	al	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	43	4	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	1	report	report	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	2	that	that	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	3	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	4	inflam-	inflam-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	5	masome	masome	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	6	activation	activation	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	7	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	8	autophagy	autophagy	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	9	induced	induce	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	10	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	11	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	12	can	can	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	13	be	be	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	14	further	further	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	15	enhanced	enhance	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	16	through	through	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	17	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	18	deletion	deletion	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	19	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	20	nuoG	nuoG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	21	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	22	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	23	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	24	ureC::hly	urec::hly	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	25	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	26	nuoG	nuog	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	27	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	28	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	29	13	13	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	30	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	44	31	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	1	The	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	2	nuoG	nuog	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	3	gene	gene	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	4	encodes	encode	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	5	NADH	NADH	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	6	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	7	quinone	quinone	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	8	oxi-	oxi-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	9	doreductase	doreductase	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	10	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	11	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	12	involved	involve	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	13	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	14	mycobacterial	mycobacterial	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	15	respiration	respiration	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	45	16	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	1	Dele-	Dele-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	2	tion	tion	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	3	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	4	this	this	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	5	gene	gene	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	6	leads	lead	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	7	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	8	enhanced	enhanced	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	9	apoptosis	apoptosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	10	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	11	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	12	host	host	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	13	cell	cell	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	14	during	during	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	15	mycobacterial	mycobacterial	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	16	infection	infection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	17	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	18	14	14	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	19	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	20	15	15	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	21	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	46	22	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	47	1	Gengenbacher	gengenbacher	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	47	2	et	et	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	47	3	al	al	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	47	4	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	1	show	show	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	2	that	that	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	3	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	4	protective	protective	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	5	efficacy	efficacy	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	6	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	7	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	8	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	9	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	10	mouse	mouse	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	11	model	model	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	12	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	13	further	further	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	14	improved	improve	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	15	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	16	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	17	deletion	deletion	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	18	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	19	nuoG	nuoG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	20	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	21	13	13	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	22	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	48	23	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	1	IMPACT	impact	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	2	OF	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	3	A	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	4	NEW	new	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	5	RECOMBINANT	recombinant	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	6	BCG	bcg	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	7	VACCINE	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	8	ON	on	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	9	THE	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	10	DEVELOPMENT	development	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	11	OF	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	12	VPM1002	vpm1002	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	13	If	if	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	14	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	15	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	16	ureC::hly	urec::hly	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	17	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	18	nuoG	nuoG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	19	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	20	more	more	RBR
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	21	effective	effective	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	22	than	than	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	23	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	24	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	25	what	what	WP
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	26	are	be	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	27	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	28	implications	implication	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	29	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	30	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	31	current	current	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	32	clinical	clinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	33	development	development	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	34	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	35	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	49	36	?	?	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	1	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	2	was	be	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	3	first	first	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	4	used	use	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	5	as	as	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	6	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	7	human	human	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	8	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	9	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	10	1921	1921	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	11	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	13	like	like	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	14	Sleeping	sleep	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	15	Beauty	Beauty	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	16	pricked	prick	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	17	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	18	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	19	spinning	spinning	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	20	wheel	wheel	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	21	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	22	we	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	23	have	have	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	24	slum-	slum-	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	25	bered	bere	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	26	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	27	100	100	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	28	years	year	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	29	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	30	depending	depend	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	31	on	on	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	32	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	33	alone	alone	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	34	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	35	protection	protection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	50	36	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	1	The	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	2	high	high	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	3	risk	risk	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	4	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	5	failure	failure	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	6	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	7	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	8	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	9	candidates	candidate	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	10	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	11	costly	costly	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	13	late	late	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	14	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	15	phase	phase	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	16	clinical	clinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	17	trials	trial	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	18	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	19	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	20	low	low	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	21	commercial	commercial	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	22	value	value	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	23	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	24	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	25	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	26	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	27	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	28	industry	industry	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	29	are	be	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	30	blamed	blame	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	31	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	32	part	part	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	33	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	34	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	35	sluggish	sluggish	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	36	pace	pace	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	37	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	38	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	39	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	40	development	development	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	41	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	42	16	16	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	43	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	51	44	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	1	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	2	may	may	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	3	be	be	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	4	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	5	first	first	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	6	new	new	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	7	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	8	generation	generation	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	9	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	10	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	11	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	12	enter	enter	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	13	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	14	market	market	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	15	as	as	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	16	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	17	safer	safe	JJR
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	18	alternative	alternative	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	19	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	20	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	21	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	22	vac-	vac-	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	23	cine	cine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	24	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	25	HIV	HIV	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	26	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	27	exposed	expose	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	28	infants	infant	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	52	29	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	1	After	after	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	2	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	3	introduction	introduction	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	4	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	5	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	7	we	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	8	should	should	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	9	not	not	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	10	sink	sink	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	11	back	back	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	12	into	into	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	13	our	-PRON-	PRP$
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	14	sleep	sleep	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	15	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	16	another	another	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	17	100	100	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	18	years	year	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	19	but	but	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	20	should	should	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	21	capitalize	capitalize	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	22	on	on	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	23	our	-PRON-	PRP$
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	24	expertise	expertise	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	25	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	26	iteratively	iteratively	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	27	improving	improve	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	28	VPM1002	vpm1002	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	29	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	30	our	-PRON-	PRP$
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	31	other	other	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	32	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	33	candidates	candidate	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	34	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	35	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	36	addition	addition	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	37	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	38	gener-	gener-	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	39	ating	ating	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	40	novel	novel	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	41	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	42	platforms	platform	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	53	43	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	1	Through	through	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	2	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	3	clinical	clinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	4	development	development	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	5	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	6	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	7	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	8	other	other	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	9	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	10	candidates	candidate	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	11	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	12	such	such	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	13	as	as	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	14	MVA85A	mva85a	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	15	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	16	we	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	17	have	have	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	18	advanced	advance	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	19	our	-PRON-	PRP$
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	20	understanding	understanding	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	21	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	22	immune	immune	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	23	correlates	correlate	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	24	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	25	built	build	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	26	capacity	capacity	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	27	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	28	clinical	clinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	29	testing	testing	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	30	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	31	biomanufacturing	biomanufacturing	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	32	that	that	WDT
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	33	will	will	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	34	greatly	greatly	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	35	accelerate	accelerate	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	36	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	37	development	development	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	38	process	process	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	39	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	40	2nd-	2nd-	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	41	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	42	3rd-	3rd-	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	43	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	44	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	45	4th-	4th-	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	46	generation	generation	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	47	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	48	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	49	candidates	candidate	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	54	50	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	1	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	2	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	3	ureC::hly	urec::hly	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	4	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	5	nuoG	nuoG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	6	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	7	our	-PRON-	PRP$
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	8	wake	wake	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	9	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	10	up	up	RP
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	11	call	call	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	13	which	which	WDT
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	14	has	have	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	15	shown	show	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	16	us	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	17	that	that	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	18	there	there	EX
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	19	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	20	potential	potential	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	21	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	22	further	further	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	23	improvement	improvement	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	24	on	on	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	25	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	26	protec-	protec-	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	27	tion	tion	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	28	induced	induce	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	29	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	30	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	31	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	32	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	55	33	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	1	We	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	2	should	should	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	3	respond	respond	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	4	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	5	this	this	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	6	call	call	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	7	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	8	action	action	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	9	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	10	increased	increase	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	11	energy	energy	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	12	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	13	investment	investment	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	14	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	15	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	16	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	17	development	development	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	56	18	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	1	IMPACT	impact	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	2	OF	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	3	A	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	4	NEW	new	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	5	RECOMBINANT	recombinant	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	6	BCG	bcg	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	7	VACCINE	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	8	ON	on	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	9	THE	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	10	CURRENTLY	CURRENTLY	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	11	USED	use	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	12	BCG	bcg	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	13	What	what	WP
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	14	are	be	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	15	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	16	implications	implication	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	17	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	18	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	19	current	current	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	20	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	21	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	22	if	if	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	23	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	24	enters	enter	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	25	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	26	market	market	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	27	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	28	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	29	next	next	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	30	5	5	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	31	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	32	10	10	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	33	years	year	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	57	34	?	?	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	1	We	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	2	should	should	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	3	not	not	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	4	forget	forget	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	5	that	that	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	6	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	7	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	8	an	an	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	9	effective	effective	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	10	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	11	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	12	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	13	prevention	prevention	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	14	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	15	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	16	disease	disease	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	17	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	18	many	many	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	19	individuals	individual	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	58	20	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	1	Enthusiasm	enthusiasm	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	2	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	3	new	new	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	4	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	5	must	must	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	6	not	not	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	7	overshadow	overshadow	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	8	support	support	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	9	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	10	an	an	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	11	existing	existing	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	13	effective	effective	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	14	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	59	15	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	1	Glob-	Glob-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	2	ally	ally	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	4	there	there	EX
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	5	have	have	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	6	been	be	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	7	shortages	shortage	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	8	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	9	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	10	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	11	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	12	supply	supply	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	13	since	since	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	14	2013	2013	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	15	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	16	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	17	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	18	situation	situation	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	19	appears	appear	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	20	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	21	be	be	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	22	worsening	worsen	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	23	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	24	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	25	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	26	shortage	shortage	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	27	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	28	8	8	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	29	million	million	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	30	doses	dose	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	31	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	32	2014	2014	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	33	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	34	17	17	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	35	million	million	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	36	doses	dose	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	37	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	38	2015	2015	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	39	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	40	17	17	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	41	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	60	42	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	1	The	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	2	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	3	shortage	shortage	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	4	has	have	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	5	highlighted	highlight	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	6	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	7	shocking	shocking	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	8	fragility	fragility	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	9	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	10	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	11	global	global	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	12	manufacturing	manufacturing	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	13	capacity	capacity	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	14	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	15	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	16	only	only	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	17	available	available	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	18	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	19	against	against	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	20	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	21	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	22	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	23	world	world	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	24	’s	’s	POS
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	25	leading	lead	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	26	cause	cause	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	27	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	28	death	death	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	29	due	due	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	30	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	31	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	32	single	single	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	33	infectious	infectious	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	34	agent	agent	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	61	35	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	1	It	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	2	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	3	not	not	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	4	clear	clear	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	5	who	who	WP
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	6	should	should	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	7	take	take	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	8	responsibility	responsibility	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	9	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	10	rebuilding	rebuild	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	11	man-	man-	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	12	ufacturing	ufacturing	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	13	capacity	capacity	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	14	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	15	protecting	protect	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	16	our	-PRON-	PRP$
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	17	BCG	bcg	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	18	supplies	supply	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	19	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	20	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	21	fu-	fu-	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	22	ture	ture	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	62	23	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	1	We	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	2	are	be	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	3	many	many	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	4	decades	decade	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	5	away	away	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	6	from	from	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	7	seeing	see	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	8	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	9	recombinant	recombinant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	10	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	11	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	12	replace	replace	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	13	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	14	current	current	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	15	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	16	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	17	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	18	global	global	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	19	use	use	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	63	20	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	1	Perhaps	perhaps	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	2	we	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	3	should	should	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	4	be	be	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	5	asking	ask	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	6	ourselves	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	7	if	if	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	8	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	9	while	while	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	10	building	building	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	11	capacity	capacity	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	12	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	13	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	14	manufacture	manufacture	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	15	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	16	recombinant	recombinant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	17	BCGs	bcg	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	18	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	19	we	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	20	also	also	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	21	have	have	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	22	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	23	moral	moral	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	24	respon-	respon-	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	25	sibility	sibility	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	26	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	27	support	support	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	28	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	29	rebuild	rebuild	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	30	capacity	capacity	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	31	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	32	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	33	manufacture	manufacture	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	34	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	35	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	36	current	current	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	37	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	38	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	64	39	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	1	SUMMARY	SUMMARY	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	2	In	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	3	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	4	next	next	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	5	5	5	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	6	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	7	10	10	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	8	years	year	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	10	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	11	recombinant	recombinant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	12	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	13	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	14	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	15	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	16	ureC::hly	urec::hly	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	17	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	18	VPM1002	VPM1002	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	19	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	20	may	may	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	21	be	be	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	22	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	23	first	first	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	24	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	25	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	26	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	27	enter	enter	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	28	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	29	market	market	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	30	since	since	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	31	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	32	was	be	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	33	first	first	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	34	used	use	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	35	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	36	1921	1921	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	65	37	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	1	Like	like	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	2	Sleeping	sleep	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	3	Beauty	Beauty	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	4	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	5	we	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	6	have	have	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	7	slumbered	slumber	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	8	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	9	100	100	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	10	years	year	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	11	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	12	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	13	current	current	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	14	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	15	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	16	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	17	show-	show-	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	18	ing	e	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	19	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	20	reluctance	reluctance	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	21	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	22	invest	invest	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	23	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	24	clinical	clinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	25	development	development	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	26	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	27	neglecting	neglecting	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	28	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	29	secure	secure	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	30	existing	exist	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	31	biomanufacturing	biomanufacturing	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	32	capacity	capacity	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	66	33	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	1	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	2	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	3	ureC::hly	urec::hly	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	4	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	5	nuoG	nuoG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	6	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	7	our	-PRON-	PRP$
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	8	wake	wake	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	9	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	10	up	up	RP
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	11	call	call	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	13	showing	show	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	14	us	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	15	that	that	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	16	we	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	17	can	can	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	18	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	19	should	should	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	20	make	make	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	21	better	well	JJR
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	22	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	23	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	24	continued	continued	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	25	effort	effort	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	67	26	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	1	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	2	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	3	develop-	develop-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	4	ment	ment	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	5	requires	require	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	6	scientists	scientist	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	7	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	8	be	be	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	9	awake	awake	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	10	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	11	alert	alert	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	12	so	so	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	13	that	that	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	14	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	15	introduc-	introduc-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	16	tion	tion	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	17	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	18	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	19	first	first	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	20	recombinant	recombinant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	21	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	22	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	23	accelerates	accelerate	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	24	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	25	does	do	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	26	not	not	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	27	stop	stop	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	28	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	29	development	development	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	30	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	31	2nd-	2nd-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	32	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	33	3rd	3rd	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	34	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	35	generation	generation	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	36	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	37	candi-	candi-	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	38	dates	date	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	68	39	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	1	Only	only	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	2	through	through	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	3	protection	protection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	4	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	5	our	-PRON-	PRP$
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	6	current	current	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	7	BCG	bcg	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	8	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	9	stocks	stock	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	10	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	11	continued	continue	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	12	investment	investment	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	13	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	14	preclinical	preclinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	15	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	16	clinical	clinical	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	17	development	development	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	18	can	can	MD
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	19	we	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	20	hope	hope	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	21	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	22	reduce	reduce	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	23	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	24	global	global	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	25	burden	burden	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	26	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	27	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	28	disease	disease	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	69	29	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	1	FUNDING	fund	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	2	INFORMATION	INFORMATION	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	3	This	this	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	4	work	work	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	5	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	6	including	include	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	7	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	8	efforts	effort	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	9	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	10	Helen	Helen	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	11	Fletcher	Fletcher	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	13	was	be	VBD
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	14	funded	fund	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	15	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	16	Euro-	Euro-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	17	pean	pean	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	18	Commission	Commission	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	19	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	20	EC	EC	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	21	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	22	(	(	-LRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	23	643381	643381	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	24	)	)	-RRB-
work_qlfchymhsrgv5gjmnyfv3kvfhi	70	25	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	71	1	REFERENCES	reference	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	71	2	1	1	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	71	3	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	1	Dye	Dye	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	2	C	C	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	4	Scheele	Scheele	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	5	S	S	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	7	Dolin	Dolin	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	8	P	P	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	10	Pathania	Pathania	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	11	V	V	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	13	Raviglione	Raviglione	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	14	MC	MC	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	72	15	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	73	1	1999	1999	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	73	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	74	1	Consensus	consensus	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	74	2	statement	statement	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	74	3	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	1	Global	global	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	2	burden	burden	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	3	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	4	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	5	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	6	estimated	estimate	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	7	incidence	incidence	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	8	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	9	preva-	preva-	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	10	lence	lence	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	11	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	12	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	13	mortality	mortality	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	14	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	15	country	country	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	75	16	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	1	WHO	who	WP
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	2	Global	Global	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	3	Surveillance	Surveillance	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	4	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	5	Monitor-	Monitor-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	6	i	i	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	7	n	n	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	8	g	g	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	9	P	p	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	10	r	r	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	11	o	o	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	12	j	j	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	13	e	e	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	14	c	c	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	15	t	t	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	76	16	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	1	J	J	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	2	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	3	M	M	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	4	A	a	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	5	2	2	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	6	8	8	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	7	2	2	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	8	:	:	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	9	6	6	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	10	7	7	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	11	7	7	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	12	–	–	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	13	6	6	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	14	8	8	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	15	6	6	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	77	16	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	78	1	h	h	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	78	2	t	t	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	78	3	t	t	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	78	4	p	p	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	78	5	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	78	6	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	78	7	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	78	8	d	d	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	78	9	x	x	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	78	10	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	79	1	d	d	LS
work_qlfchymhsrgv5gjmnyfv3kvfhi	79	2	o	o	XX
work_qlfchymhsrgv5gjmnyfv3kvfhi	79	3	i	i	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	79	4	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	80	1	o	o	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	80	2	r	r	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	80	3	g	g	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	80	4	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	80	5	1	1	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	80	6	0	0	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	80	7	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	81	1	1	1	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	81	2	0	0	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	81	3	0	0	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	81	4	1	1	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	81	5	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	81	6	jama.282.7.677	jama.282.7.677	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	81	7	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	82	1	2	2	LS
work_qlfchymhsrgv5gjmnyfv3kvfhi	82	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	82	3	WHO	who	WP
work_qlfchymhsrgv5gjmnyfv3kvfhi	82	4	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	83	1	2015	2015	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	83	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	84	1	Global	global	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	84	2	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	84	3	report	report	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	84	4	2015	2015	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	84	5	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	85	1	World	World	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	85	2	Health	Health	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	85	3	Organiza-	Organiza-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	85	4	tion	tion	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	85	5	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	85	6	Geneva	Geneva	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	85	7	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	85	8	Switzerland	Switzerland	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	85	9	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	86	1	http://www.who.int/tb/publications/	http://www.who.int/tb/publications/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	86	2	global_report	global_report	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	86	3	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	86	4	en/.	en/.	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	87	1	3	3	LS
work_qlfchymhsrgv5gjmnyfv3kvfhi	87	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	1	Lönnroth	Lönnroth	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	2	K	K	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	4	Migliori	Migliori	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	5	GB	GB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	7	Abubakar	Abubakar	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	8	I	I	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	10	D’Ambrosio	D’Ambrosio	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	11	L	L	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	13	de	de	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	14	Vries	Vries	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	15	G	G	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	16	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	17	Diel	Diel	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	18	R	R	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	19	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	20	Douglas	Douglas	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	21	P	P	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	22	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	23	Falzon	Falzon	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	24	D	D	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	25	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	26	Gaudreau	Gaudreau	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	27	MA	MA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	28	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	29	Goletti	Goletti	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	30	D	D	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	31	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	32	González	González	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	33	Ochoa	Ochoa	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	34	ER	ER	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	35	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	36	LoBue	LoBue	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	37	P	P	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	38	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	39	Matteelli	Matteelli	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	40	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	41	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	42	Njoo	Njoo	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	43	H	H	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	44	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	45	Solovic	Solovic	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	46	I	I	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	47	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	48	Story	Story	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	49	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	50	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	51	Tayeb	Tayeb	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	52	T	T	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	53	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	54	van	van	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	55	der	der	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	56	Werf	Werf	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	57	MJ	MJ	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	58	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	59	Weil	Weil	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	60	D	D	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	61	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	62	Zellweger	Zellweger	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	63	JP	JP	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	64	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	65	Abdel	Abdel	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	66	AM	AM	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	67	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	68	Al	Al	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	69	Lawati	Lawati	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	70	MR	MR	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	71	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	72	Aliberti	Aliberti	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	73	S	S	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	74	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	75	Arrazola	Arrazola	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	76	de	de	FW
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	77	Onate	Onate	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	78	W	W	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	79	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	80	Barreira	Barreira	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	81	D	D	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	82	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	83	Bhatia	Bhatia	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	84	V	V	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	85	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	86	Blasi	Blasi	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	87	F	F	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	88	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	89	Bloom	Bloom	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	90	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	91	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	92	Bruchfeld	Bruchfeld	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	93	J	J	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	94	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	95	Castelli	Castelli	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	96	F	F	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	97	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	98	Centis	Centis	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	99	R	R	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	100	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	101	Chemtob	Chemtob	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	102	D	D	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	103	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	104	Cirillo	Cirillo	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	105	DM	DM	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	106	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	107	Colorado	Colorado	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	108	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	109	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	110	Dadu	Dadu	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	111	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	112	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	113	Dahle	Dahle	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	114	UR	UR	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	115	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	116	De	De	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	117	Paoli	Paoli	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	118	L	L	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	119	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	120	Dias	Dias	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	121	HM	HM	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	122	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	123	Duarte	Duarte	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	124	R	R	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	125	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	126	Fattorini	Fattorini	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	127	L	L	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	128	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	129	Gaga	Gaga	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	130	M	M	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	131	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	132	Getahun	Getahun	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	133	H	H	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	134	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	135	Glaziou	Glaziou	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	136	P	P	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	137	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	138	Goguadze	Goguadze	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	139	L	L	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	140	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	141	Del	Del	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	142	Granado	Granado	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	143	M	M	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	144	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	145	Haas	Haas	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	146	W	W	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	147	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	148	Jarvinen	Jarvinen	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	149	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	150	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	151	Kwon	Kwon	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	152	GY	GY	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	153	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	154	Mosca	Mosca	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	155	D	D	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	156	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	157	Nahid	Nahid	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	158	P	P	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	159	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	160	et	et	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	161	al	al	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	88	162	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	89	1	2015	2015	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	89	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	1	Towards	towards	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	2	tuberculosis	tuberculosis	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	3	elimination	elimination	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	4	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	5	an	an	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	6	action	action	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	7	framework	framework	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	8	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	9	low	low	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	10	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	11	incidence	incidence	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	12	countries	country	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	90	13	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	91	1	Eur	Eur	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	91	2	Respir	Respir	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	91	3	J	J	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	91	4	45:928	45:928	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	91	5	–	–	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	91	6	952	952	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	91	7	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	92	1	http://dx.doi.org/10.1183/09031936.00214014	http://dx.doi.org/10.1183/09031936.00214014	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	92	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	93	1	4	4	LS
work_qlfchymhsrgv5gjmnyfv3kvfhi	93	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	1	Behr	Behr	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	2	MA	MA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	4	Wilson	Wilson	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	5	MA	MA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	7	Gill	Gill	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	8	WP	WP	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	10	Salamon	Salamon	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	11	H	H	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	13	Schoolnik	Schoolnik	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	14	GK	GK	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	15	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	16	Rane	Rane	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	17	S	S	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	18	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	19	Small	small	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	20	PM	PM	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	94	21	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	95	1	1999	1999	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	95	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	96	1	Comparative	comparative	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	96	2	genomics	genomic	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	96	3	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	96	4	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	96	5	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	96	6	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	96	7	whole-	whole-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	96	8	genome	genome	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	96	9	DNA	DNA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	96	10	microarray	microarray	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	96	11	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	97	1	Science	science	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	97	2	284:1520	284:1520	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	97	3	–	–	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	97	4	1523	1523	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	97	5	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	98	1	http://dx.doi.org/	http://dx.doi.org/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	98	2	10.1126	10.1126	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	98	3	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	98	4	science.284.5419.1520	science.284.5419.1520	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	98	5	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	99	1	5	5	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	99	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	1	Mangtani	Mangtani	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	2	P	P	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	4	Abubakar	Abubakar	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	5	I	I	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	7	Ariti	Ariti	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	8	C	C	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	10	Beynon	Beynon	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	11	R	R	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	13	Pimpin	Pimpin	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	14	L	L	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	15	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	16	Fine	fine	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	17	PE	PE	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	18	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	19	Rodrigues	Rodrigues	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	20	LC	LC	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	21	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	22	Smith	Smith	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	23	PG	PG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	24	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	25	Lipman	Lipman	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	26	M	M	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	27	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	28	Whiting	Whiting	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	29	PF	PF	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	30	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	31	Sterne	Sterne	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	32	JA	JA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	100	33	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	101	1	2014	2014	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	101	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	1	Protection	protection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	2	by	by	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	3	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	4	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	5	against	against	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	6	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	7	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	8	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	9	systematic	systematic	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	10	review	review	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	11	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	12	randomized	randomized	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	13	controlled	controlled	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	14	trials	trial	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	102	15	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	103	1	Clin	Clin	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	103	2	Infect	Infect	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	103	3	Dis	Dis	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	103	4	58:470	58:470	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	103	5	–	–	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	103	6	480	480	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	103	7	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	103	8	http://	http://	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	103	9	dx.doi.org/10.1093/cid/cit790	dx.doi.org/10.1093/cid/cit790	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	103	10	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	104	1	6	6	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	104	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	1	Fletcher	Fletcher	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	2	HA	HA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	4	Snowden	Snowden	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	5	MA	MA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	7	Landry	Landry	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	8	B	B	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	10	Rida	Rida	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	11	W	W	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	13	Satti	Satti	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	14	I	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	15	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	16	Harris	Harris	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	17	SA	SA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	18	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	19	Matsumiya	Matsumiya	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	20	M	M	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	21	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	22	Tanner	Tanner	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	23	R	R	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	24	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	25	O’Shea	o’shea	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	26	MK	MK	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	27	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	28	Dheenadhayalan	Dheenadhayalan	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	29	V	V	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	30	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	31	Bogardus	Bogardus	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	32	L	L	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	33	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	34	Stockdale	Stockdale	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	35	L	L	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	36	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	37	Marsay	Marsay	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	38	L	L	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	39	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	40	Chomka	Chomka	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	41	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	42	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	43	Harrington	Harrington	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	44	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	45	Kandt	Kandt	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	46	R	R	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	47	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	48	Manjaly-	Manjaly-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	49	Thomas	Thomas	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	50	ZR	ZR	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	51	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	52	Naranbhai	Naranbhai	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	53	V	V	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	54	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	55	Stylianou	Stylianou	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	56	E	E	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	57	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	58	Darboe	Darboe	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	59	F	F	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	60	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	61	Penn	Penn	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	62	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	63	Nicholson	Nicholson	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	64	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	65	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	66	Nemes	Nemes	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	67	E	E	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	68	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	69	Hatheril	Hatheril	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	70	M	M	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	71	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	72	Hussey	Hussey	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	73	G	G	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	74	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	75	Mahomed	Mahomed	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	76	H	H	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	77	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	78	Tameris	Tameris	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	79	M	M	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	80	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	81	McClain	McClain	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	82	JB	JB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	83	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	84	Evans	Evans	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	85	TG	TG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	86	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	87	Hanekom	Hanekom	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	88	WA	WA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	89	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	90	Scriba	Scriba	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	91	TJ	TJ	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	92	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	93	McShane	McShane	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	94	H.	H.	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	95	2016	2016	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	105	96	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	1	T	t	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	2	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	3	cell	cell	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	4	activation	activation	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	5	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	6	an	an	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	7	immune	immune	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	8	correlate	correlate	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	9	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	10	risk	risk	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	11	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	12	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	13	vaccinated	vaccinated	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	14	infants	infant	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	106	15	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	107	1	Nat	Nat	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	107	2	Commun	Commun	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	107	3	7:11290	7:11290	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	107	4	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	107	5	http://dx.doi.org/10.1038/ncomms11290	http://dx.doi.org/10.1038/ncomms11290	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	107	6	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	108	1	7	7	LS
work_qlfchymhsrgv5gjmnyfv3kvfhi	108	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	109	1	Fletcher	Fletcher	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	109	2	HA	HA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	109	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	109	4	Schrager	Schrager	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	109	5	L.	L.	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	109	6	2016	2016	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	109	7	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	1	TB	tb	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	2	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	3	development	development	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	4	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	5	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	6	End	End	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	7	TB	TB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	8	Strategy	Strategy	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	9	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	10	importance	importance	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	11	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	12	current	current	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	13	status	status	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	110	14	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	111	1	Trans	Trans	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	111	2	R	R	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	111	3	Soc	Soc	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	111	4	Trop	Trop	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	111	5	Med	Med	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	111	6	Hyg	Hyg	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	111	7	110	110	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	111	8	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	111	9	212–218	212–218	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	111	10	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	112	1	http://dx.doi.org/10.1093/trstmh/trw016	http://dx.doi.org/10.1093/trstmh/trw016	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	112	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	1	Commentary	commentary	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	2	2	2	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	3	®	®	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	4	mbio.asm.org	mbio.asm.org	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	5	July	July	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	6	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	7	August	August	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	8	2016	2016	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	9	Volume	volume	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	10	7	7	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	11	Issue	issue	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	12	4	4	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	13	e01370	e01370	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	14	-	-	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	15	16	16	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	16	o	o	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	17	n	n	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	18	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	19	p	p	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	20	ril	ril	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	21	5	5	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	22	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	23	2	2	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	24	0	0	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	25	2	2	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	26	1	1	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	27	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	28	t	t	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	29	C	c	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	30	A	a	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	31	R	r	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	32	N	n	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	33	E	e	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	34	G	g	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	35	IE	ie	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	36	M	m	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	37	E	e	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	38	L	l	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	39	L	l	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	40	O	o	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	41	N	N	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	42	U	U	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	43	N	N	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	44	IV	IV	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	45	L	L	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	46	IB	IB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	47	R	r	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	48	h	h	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	49	ttp	ttp	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	50	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	51	//m	//m	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	52	b	b	UH
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	53	io	io	UH
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	54	.a	.a	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	55	sm	sm	FW
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	56	.o	.o	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	57	rg	rg	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	58	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	59	D	D	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	60	o	o	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	61	w	w	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	62	n	n	XX
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	63	lo	lo	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	64	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	65	d	d	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	66	e	e	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	67	d	d	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	68	fro	fro	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	69	m	m	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	70	http://indianexpress.com/article/explained/a-new-tb-vaccine-is-in-the-works-and-heres-why-india-is-excited/	http://indianexpress.com/article/explained/a-new-tb-vaccine-is-in-the-works-and-heres-why-india-is-excited/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	71	http://indianexpress.com/article/explained/a-new-tb-vaccine-is-in-the-works-and-heres-why-india-is-excited/	http://indianexpress.com/article/explained/a-new-tb-vaccine-is-in-the-works-and-heres-why-india-is-excited/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	72	http://indianexpress.com/article/explained/a-new-tb-vaccine-is-in-the-works-and-heres-why-india-is-excited/	http://indianexpress.com/article/explained/a-new-tb-vaccine-is-in-the-works-and-heres-why-india-is-excited/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	73	http://dx.doi.org/10.1001/jama.282.7.677	http://dx.doi.org/10.1001/jama.282.7.677	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	74	http://dx.doi.org/10.1001/jama.282.7.677	http://dx.doi.org/10.1001/jama.282.7.677	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	75	http://www.who.int/tb/publications/global_report/en/	http://www.who.int/tb/publications/global_report/en/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	76	http://www.who.int/tb/publications/global_report/en/	http://www.who.int/tb/publications/global_report/en/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	77	http://dx.doi.org/10.1183/09031936.00214014	http://dx.doi.org/10.1183/09031936.00214014	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	78	http://dx.doi.org/10.1126/science.284.5419.1520	http://dx.doi.org/10.1126/science.284.5419.1520	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	79	http://dx.doi.org/10.1126/science.284.5419.1520	http://dx.doi.org/10.1126/science.284.5419.1520	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	80	http://dx.doi.org/10.1093/cid/cit790	http://dx.doi.org/10.1093/cid/cit790	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	81	http://dx.doi.org/10.1093/cid/cit790	http://dx.doi.org/10.1093/cid/cit790	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	82	http://dx.doi.org/10.1038/ncomms11290	http://dx.doi.org/10.1038/ncomms11290	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	83	http://dx.doi.org/10.1093/trstmh/trw016	http://dx.doi.org/10.1093/trstmh/trw016	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	84	mbio.asm.org	mbio.asm.org	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	85	http://mbio.asm.org/	http://mbio.asm.org/	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	86	8	8	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	113	87	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	1	Grode	Grode	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	2	L	L	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	4	Seiler	Seiler	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	5	P	P	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	7	Baumann	Baumann	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	8	S	S	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	10	Hess	Hess	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	11	J	J	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	13	Brinkmann	Brinkmann	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	14	V	V	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	15	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	16	Nasser	Nasser	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	17	Eddine	Eddine	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	18	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	19	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	20	Mann	Mann	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	21	P	P	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	22	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	23	Goosmann	Goosmann	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	24	C	C	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	25	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	26	Bandermann	Bandermann	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	27	S	S	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	28	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	29	Smith	Smith	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	30	D	D	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	31	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	32	Bancroft	Bancroft	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	33	GJ	GJ	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	34	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	35	Reyrat	Reyrat	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	36	JM	JM	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	37	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	38	van	van	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	39	Soolingen	Soolingen	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	40	D	D	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	41	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	42	Raupach	Raupach	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	43	B	B	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	44	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	45	Kaufmann	Kaufmann	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	46	SH	SH	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	114	47	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	115	1	2005	2005	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	115	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	1	Increased	increase	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	2	vac-	vac-	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	3	cine	cine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	4	efficacy	efficacy	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	5	against	against	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	6	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	7	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	8	recombinant	recombinant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	9	Mycobacterium	Mycobacterium	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	10	bovis	bovis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	11	Bacille	Bacille	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	12	Calmette	Calmette	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	13	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	14	Guerin	Guerin	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	15	mutants	mutant	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	16	that	that	WDT
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	17	secrete	secrete	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	18	listeriolysin	listeriolysin	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	116	19	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	117	1	J	J	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	117	2	Clin	Clin	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	117	3	Invest	Invest	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	117	4	115:2472–2479	115:2472–2479	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	117	5	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	118	1	http://dx.doi.org/10.1172/JCI24617	http://dx.doi.org/10.1172/jci24617	ADD
work_qlfchymhsrgv5gjmnyfv3kvfhi	118	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	119	1	9	9	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	119	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	1	Saiga	saiga	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	2	H	H	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	4	Nieuwenhuizen	Nieuwenhuizen	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	5	N	N	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	7	Gengenbacher	Gengenbacher	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	8	M	M	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	10	Koehler	Koehler	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	11	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	12	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	13	B	B	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	14	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	15	Schuerer	Schuerer	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	16	S	S	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	17	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	18	Moura	Moura	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	19	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	20	Alves	Alves	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	21	P	P	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	22	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	23	Wagner	Wagner	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	24	I	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	25	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	26	Mollenkopf	Mollenkopf	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	27	H	H	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	28	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	29	J	J	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	30	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	31	Dorhoi	Dorhoi	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	32	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	33	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	34	Kaufmann	Kaufmann	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	35	SHE	SHE	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	120	36	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	121	1	2015	2015	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	121	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	1	The	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	2	recombinant	recombinant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	3	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	4	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	5	ureC::hly	urec::hly	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	6	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	7	targets	target	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	8	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	9	AIM2	AIM2	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	10	inflam-	inflam-	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	11	masome	masome	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	12	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	13	induce	induce	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	14	autophagy	autophagy	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	15	and	and	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	16	inflammation	inflammation	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	122	17	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	123	1	J	J	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	123	2	Infect	Infect	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	123	3	Dis	Dis	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	123	4	211	211	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	123	5	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	123	6	1831–1841	1831–1841	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	123	7	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	124	1	http://dx.doi.org/10.1093/infdis/jiu675	http://dx.doi.org/10.1093/infdis/jiu675	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	124	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	125	1	10	10	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	125	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	1	Vogelzang	Vogelzang	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	2	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	4	Perdomo	Perdomo	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	5	C	C	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	7	Zedler	Zedler	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	8	U	U	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	10	Kuhlmann	Kuhlmann	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	11	S	S	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	13	Hurwitz	Hurwitz	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	14	R	R	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	15	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	16	Gengen-	Gengen-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	17	bacher	bacher	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	18	M	M	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	19	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	20	Kaufmann	Kaufmann	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	21	SH	SH	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	126	22	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	127	1	2014	2014	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	127	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	1	Central	central	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	2	memory	memory	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	3	CD4	CD4	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	4	�	�	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	5	T	t	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	6	cells	cell	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	7	are	be	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	8	re-	re-	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	9	sponsible	sponsible	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	10	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	11	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	12	recombinant	recombinant	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	13	Bacillus	Bacillus	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	14	Calmette	Calmette	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	15	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	16	Guerin	Guerin	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	17	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	18	ureC::hly	urec::hly	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	19	vac-	vac-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	20	cine	cine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	21	’s	’s	POS
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	22	superior	superior	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	23	protection	protection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	24	against	against	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	25	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	128	26	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	129	1	J	J	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	129	2	Infect	Infect	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	129	3	Dis	Dis	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	129	4	210	210	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	129	5	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	129	6	1928	1928	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	129	7	–	–	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	129	8	1937	1937	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	129	9	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	130	1	http://dx.doi.org/10.1093/infdis/jiu347	http://dx.doi.org/10.1093/infdis/jiu347	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	130	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	131	1	11	11	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	131	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	132	1	Grode	Grode	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	132	2	LB	LB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	132	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	132	4	Søgaard	Søgaard	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	132	5	A.	a.	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	133	1	2014	2014	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	133	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	1	Improvement	improvement	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	2	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	3	nutritional	nutritional	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	4	care	care	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	5	after	after	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	6	colon	colon	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	7	surgery	surgery	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	8	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	9	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	10	impact	impact	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	11	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	12	early	early	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	13	oral	oral	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	14	nutrition	nutrition	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	15	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	16	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	17	postanesthesia	postanesthesia	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	18	care	care	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	19	unit	unit	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	134	20	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	135	1	J	J	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	135	2	Perianesth	Perianesth	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	135	3	Nurs	Nurs	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	135	4	29:266	29:266	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	135	5	–	–	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	135	6	274	274	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	135	7	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	136	1	http://dx.doi.org/10.1016/	http://dx.doi.org/10.1016/	UH
work_qlfchymhsrgv5gjmnyfv3kvfhi	136	2	j.jopan.2013.09.009	j.jopan.2013.09.009	$
work_qlfchymhsrgv5gjmnyfv3kvfhi	136	3	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	137	1	12	12	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	137	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	1	Scriven	Scriven	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	2	JE	JE	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	4	Graham	Graham	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	5	LM	LM	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	7	Schutz	Schutz	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	8	C	C	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	10	Scriba	Scriba	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	11	TJ	TJ	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	13	Wilkinson	Wilkinson	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	14	KA	KA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	15	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	16	Wilkinson	Wilkinson	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	17	RJ	RJ	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	18	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	19	Boulware	Boulware	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	20	DR	DR	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	21	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	22	Urban	Urban	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	23	BC	BC	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	24	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	25	Lalloo	Lalloo	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	26	DG	DG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	27	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	28	Meintjes	Meintjes	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	29	G.	G.	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	30	2016	2016	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	138	31	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	139	1	Vaccination	vaccination	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	139	2	against	against	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	139	3	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	139	4	with	with	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	139	5	whole	whole	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	139	6	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	139	7	cell	cell	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	139	8	mycobacterial	mycobacterial	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	139	9	vaccines	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	139	10	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	140	1	J	J	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	140	2	Infect	Infect	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	140	3	Dis	Dis	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	140	4	213:1725–1734	213:1725–1734	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	140	5	http://dx.doi.org/10.1093/infdis/jiw228	http://dx.doi.org/10.1093/infdis/jiw228	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	140	6	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	141	1	13	13	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	141	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	1	Gengenbacher	Gengenbacher	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	2	M	M	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	4	Nieuwenhuizen	Nieuwenhuizen	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	5	N	N	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	7	Vogelzang	Vogelzang	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	8	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	10	Liu	Liu	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	11	H	H	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	13	Kaiser	Kaiser	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	14	P	P	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	15	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	16	Schuerer	Schuerer	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	17	S	S	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	18	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	19	Lazar	Lazar	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	20	D	D	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	21	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	22	Wagner	Wagner	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	23	I	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	24	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	25	Mollenkopf	Mollenkopf	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	26	HJ	HJ	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	27	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	28	Kaufmann	Kaufmann	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	29	SH	SH	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	142	30	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	143	1	2016	2016	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	143	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	1	Deletion	deletion	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	2	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	3	nuoG	nuoG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	4	from	from	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	5	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	6	vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	7	candidate	candidate	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	8	Mycobacterium	Mycobacterium	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	9	bovis	bovi	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	10	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	11	�	�	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	12	ureC::hly	urec::hly	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	13	improves	improve	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	14	protection	protection	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	15	against	against	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	16	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	144	17	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	145	1	mBio	mBio	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	145	2	7	7	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	145	3	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	145	4	e00649	e00649	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	145	5	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	145	6	16	16	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	145	7	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	146	1	http://dx.doi.org/10.1128/mBio.00679-16	http://dx.doi.org/10.1128/mBio.00679-16	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	146	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	147	1	14	14	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	147	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	1	Velmurugan	Velmurugan	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	2	K	K	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	4	Chen	Chen	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	5	B	B	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	7	Miller	Miller	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	8	JL	JL	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	10	Azogue	Azogue	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	11	S	S	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	12	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	13	Gurses	Gurses	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	14	S	S	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	15	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	16	Hsu	Hsu	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	17	T	T	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	18	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	19	Glickman	Glickman	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	20	M	M	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	21	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	22	Jacobs	Jacobs	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	23	WR	WR	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	24	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	25	Jr.	Jr.	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	26	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	27	Porcelli	Porcelli	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	28	SA	SA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	29	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	30	Briken	Briken	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	31	V.	V.	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	32	2007	2007	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	148	33	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	1	Mycobac-	Mycobac-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	2	terium	terium	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	3	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	4	nuoG	nuoG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	5	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	6	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	7	virulence	virulence	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	8	gene	gene	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	9	that	that	WDT
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	10	inhibits	inhibit	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	11	apoptosis	apoptosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	12	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	13	infected	infected	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	14	host	host	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	15	cells	cell	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	149	16	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	150	1	PLoS	PLoS	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	150	2	Pathog	Pathog	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	150	3	3	3	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	150	4	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	150	5	e110	e110	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	150	6	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	151	1	http://dx.doi.org/10.1371/	http://dx.doi.org/10.1371/	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	151	2	journal.ppat.0030110	journal.ppat.0030110	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	151	3	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	152	1	15	15	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	152	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	1	Miller	Miller	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	2	JL	JL	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	4	Velmurugan	Velmurugan	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	5	K	K	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	7	Cowan	Cowan	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	8	MJ	MJ	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	10	Briken	Briken	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	11	V.	V.	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	12	2010	2010	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	153	13	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	1	The	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	2	type	type	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	3	I	-PRON-	PRP
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	4	Nadh	Nadh	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	5	dehydrogenase	dehydrogenase	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	6	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	7	Mycobacterium	Mycobacterium	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	8	tuberculosis	tuberculosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	9	counters	counter	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	10	phagosomal	phagosomal	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	11	NOX2	NOX2	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	12	activity	activity	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	13	to	to	TO
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	14	inhibit	inhibit	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	15	TNF	TNF	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	16	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	17	alpha	alpha	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	18	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	19	mediated	mediate	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	20	host	host	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	21	cell	cell	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	22	apoptosis	apoptosis	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	154	23	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	155	1	PLoS	PLoS	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	155	2	Pathog	Pathog	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	155	3	6	6	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	155	4	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	155	5	e1000864	e1000864	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	155	6	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	156	1	http://dx.doi.org/10.1371/journal.ppat.1000864	http://dx.doi.org/10.1371/journal.ppat.1000864	ADD
work_qlfchymhsrgv5gjmnyfv3kvfhi	156	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	157	1	16	16	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	157	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	158	1	Graham	Graham	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	158	2	BS	BS	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	158	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	158	4	Ledgerwood	Ledgerwood	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	158	5	JE	JE	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	158	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	158	7	Nabel	Nabel	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	158	8	GJ	GJ	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	158	9	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	159	1	2009	2009	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	159	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	1	Vaccine	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	2	development	development	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	3	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	4	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	5	twenty	twenty	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	6	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	7	first	first	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	8	century	century	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	9	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	10	changing	change	VBG
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	11	paradigms	paradigm	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	12	for	for	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	13	elusive	elusive	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	14	viruses	virus	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	160	15	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	161	1	Clin	Clin	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	161	2	Phar-	Phar-	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	161	3	macol	macol	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	161	4	Ther	Ther	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	161	5	86:234	86:234	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	161	6	–	–	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	161	7	236	236	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	161	8	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	162	1	http://dx.doi.org/10.1038/clpt.2009.128	http://dx.doi.org/10.1038/clpt.2009.128	UH
work_qlfchymhsrgv5gjmnyfv3kvfhi	162	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	163	1	17	17	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	163	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	1	Marais	Marais	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	2	BJ	BJ	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	3	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	4	Seddon	Seddon	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	5	JA	JA	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	6	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	7	Detjen	Detjen	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	8	AK	AK	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	9	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	10	van	van	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	11	der	der	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	12	Werf	Werf	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	13	MJ	MJ	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	14	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	15	Grzemska	Grzemska	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	16	M	M	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	17	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	18	Hesseling	Hesseling	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	19	AC	AC	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	20	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	21	Curtis	Curtis	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	22	N	N	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	23	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	24	Graham	Graham	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	25	SM	SM	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	26	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	27	Whoct	Whoct	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	28	S.	S.	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	29	2016	2016	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	164	30	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	165	1	Interrupted	interrupted	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	165	2	BCG	BCG	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	165	3	vaccination	vaccination	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	165	4	is	be	VBZ
work_qlfchymhsrgv5gjmnyfv3kvfhi	165	5	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	165	6	major	major	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	165	7	threat	threat	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	165	8	to	to	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	165	9	global	global	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	165	10	child	child	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	165	11	health	health	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	165	12	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	166	1	Lancet	Lancet	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	166	2	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	167	1	Respir	Respir	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	167	2	Med	Med	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	167	3	4:251–253	4:251–253	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	167	4	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	1	The	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	2	views	view	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	3	expressed	express	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	4	in	in	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	5	this	this	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	6	Commentary	Commentary	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	7	do	do	VBP
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	8	not	not	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	9	necessarily	necessarily	RB
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	10	reflect	reflect	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	11	the	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	12	views	view	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	13	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	14	this	this	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	15	journal	journal	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	16	or	or	CC
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	17	of	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	18	ASM	ASM	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	168	19	.	.	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	1	Commentary	Commentary	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	2	July	July	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	3	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	4	August	August	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	5	2016	2016	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	6	Volume	volume	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	7	7	7	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	8	Issue	issue	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	9	4	4	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	10	e01370	e01370	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	11	-	-	HYPH
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	12	16	16	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	13	®	®	NNPS
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	14	mbio.asm.org	mbio.asm.org	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	15	3	3	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	16	o	o	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	17	n	n	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	18	A	A	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	19	p	p	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	20	ril	ril	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	21	5	5	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	22	,	,	,
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	23	2	2	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	24	0	0	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	25	2	2	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	26	1	1	CD
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	27	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	28	t	t	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	29	C	c	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	30	A	a	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	31	R	r	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	32	N	n	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	33	E	e	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	34	G	g	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	35	IE	ie	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	36	M	m	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	37	E	e	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	38	L	l	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	39	L	l	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	40	O	o	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	41	N	N	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	42	U	U	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	43	N	N	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	44	IV	IV	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	45	L	L	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	46	IB	IB	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	47	R	r	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	48	h	h	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	49	ttp	ttp	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	50	:	:	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	51	//m	//m	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	52	b	b	UH
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	53	io	io	UH
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	54	.a	.a	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	55	sm	sm	FW
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	56	.o	.o	.
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	57	rg	rg	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	58	/	/	SYM
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	59	D	D	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	60	o	o	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	61	w	w	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	62	n	n	XX
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	63	lo	lo	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	64	a	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	65	d	d	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	66	e	e	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	67	d	d	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	68	fro	fro	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	69	m	m	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	70	http://dx.doi.org/10.1172/JCI24617	http://dx.doi.org/10.1172/JCI24617	:
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	71	http://dx.doi.org/10.1093/infdis/jiu675	http://dx.doi.org/10.1093/infdis/jiu675	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	72	http://dx.doi.org/10.1093/infdis/jiu347	http://dx.doi.org/10.1093/infdis/jiu347	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	73	http://dx.doi.org/10.1016/j.jopan.2013.09.009	http://dx.doi.org/10.1016/j.jopan.2013.09.009	FW
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	74	http://dx.doi.org/10.1016/j.jopan.2013.09.009	http://dx.doi.org/10.1016/j.jopan.2013.09.009	FW
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	75	http://dx.doi.org/10.1093/infdis/jiw228	http://dx.doi.org/10.1093/infdis/jiw228	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	76	http://dx.doi.org/10.1128/mBio.00679-16	http://dx.doi.org/10.1128/mBio.00679-16	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	77	http://dx.doi.org/10.1371/journal.ppat.0030110	http://dx.doi.org/10.1371/journal.ppat.0030110	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	78	http://dx.doi.org/10.1371/journal.ppat.0030110	http://dx.doi.org/10.1371/journal.ppat.0030110	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	79	http://dx.doi.org/10.1371/journal.ppat.1000864	http://dx.doi.org/10.1371/journal.ppat.1000864	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	80	http://dx.doi.org/10.1038/clpt.2009.128	http://dx.doi.org/10.1038/clpt.2009.128	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	81	mbio.asm.org	mbio.asm.org	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	82	http://mbio.asm.org/	http://mbio.asm.org/	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	83	BACKGROUND	background	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	84	RECOMBINANT	recombinant	VB
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	85	BCG	bcg	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	86	VACCINES	vaccine	NNS
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	87	IMPACT	impact	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	88	OF	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	89	A	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	90	NEW	new	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	91	RECOMBINANT	recombinant	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	92	BCG	bcg	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	93	VACCINE	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	94	ON	on	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	95	THE	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	96	DEVELOPMENT	DEVELOPMENT	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	97	OF	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	98	VPM1002	vpm1002	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	99	IMPACT	impact	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	100	OF	of	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	101	A	a	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	102	NEW	new	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	103	RECOMBINANT	recombinant	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	104	BCG	bcg	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	105	VACCINE	vaccine	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	106	ON	on	IN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	107	THE	the	DT
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	108	CURRENTLY	CURRENTLY	NNP
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	109	USED	use	VBN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	110	BCG	bcg	JJ
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	111	SUMMARY	summary	NN
work_qlfchymhsrgv5gjmnyfv3kvfhi	169	112	REFERENCES	reference	NNS